Advantage Alpha Capital Partners »

Biosante Pharmaceuticals shares owned by Advantage Alpha Capital Partners

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Advantage Alpha Capital Partners from 13F filings

Historical chart of Advantage Alpha Capital Partners investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Advantage Alpha Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Advantage Alpha Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $582k 6.4k 91.60
2025-06-30 $519k 8.0k 65.25
2025-03-31 $683k 10k 66.95
2024-12-31 $1.5k 27 55.30
2024-09-30 $344k 5.8k 59.66